Role of the linear-quadratic model in high doses per fraction

Radiotherapy and Oncology

Volumn 94, Issue 1, 2010, Pages 122-123

  Gay, H ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRACHIAL PLEXUS; CANCER CONTROL; CANCER STAGING; HUMAN; LETTER; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; STATISTICAL MODEL; STEREOTACTIC BODY RADIATION THERAPY;

EID: 74549118363     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2009.08.039     Document Type: Letter

References (5)

1. Fowler J.F., Tome W.A., Fenwick J.D., et al. A challenge to traditional radiation oncology. Int J Radiat Oncol Biol Phys 60 (2004) 1241-1256
2. Brenner D.J. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 18 (2008) 234-239
3. Kirkpatrick J.P., Meyer J.J., and Marks L.B. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 18 (2008) 240-243
4. Forquer J.A., Fakiris A.J., Timmerman R.D., et al. Brachial plexopathy from stereotactic body radiotherapy in early-stage NSCLC: dose-limiting toxicity in apical tumor sites. Radiother Oncol 93 (2009) 408-413
5. Gay H.A., Sibata C.H., Allison R.R., et al. Isodose-based methodology for minimizing the morbidity and mortality of thoracic hypofractionated radiotherapy. Radiother Oncol 91 (2009) 369-378